Disclosure under regulation 29(2) of SEBI(SAST) Regulations, 2011 received from Jagdish Agrawal, Promoter (M.D.)
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Jagdish Agrawal, Promoter and Managing Director of Ishita Drugs & Industries Ltd, purchased 2,200 equity shares of Rs. 10 each through the open market on December 26, 2025. His holding rose from 1,29,355 shares (4.33%) to 1,31,555 shares (4.40%) of the company's paid-up capital. The total equity share capital of the company remained unchanged at Rs. 2,99,03,000 (29,90,300 shares). The disclosure was filed under SEBI (SAST) Regulations, 2011.
This is a small open-market purchase by the promoter, signalling modest confidence in the company. The change is marginal (just 0.07% increase), so there is no meaningful impact on shareholding pattern or stock price from this transaction alone.